NCT01499498View on ClinicalTrials.gov

The Boceprevir and Sildenafil Pharmacokinetics Study

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2014

Conditions
Hepatitis C
Interventions
DRUG

Sildenafil and Boceprevir

25mg once/800mg three times a day

Trial Locations (1)

W2 1NY

Imperial College Healthcare NHS Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT01499498 - The Boceprevir and Sildenafil Pharmacokinetics Study | Biotech Hunter | Biotech Hunter